Cargando…
Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
BACKGROUND: Surgeons aim for R0 resection in patients with pancreatic cancer to improve overall survival. However, it is unclear whether recent changes in pancreatic cancer care such as centralization, increased use of neoadjuvant therapy, minimally invasive surgery, and standardized pathology repor...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319672/ https://www.ncbi.nlm.nih.gov/pubmed/37210448 http://dx.doi.org/10.1245/s10434-023-13465-9 |
_version_ | 1785068289115815936 |
---|---|
author | Augustinus, Simone Schafrat, Pascale J. M. Janssen, Boris V. Bonsing, Bert A. Brosens, Lodewijk A. A. Busch, Olivier R. Crobach, Stijn Doukas, Michail van Eijck, Casper H. van der Geest, Lydia G. M. Groot Koerkamp, Bas de Hingh, Ignace H. J. T. Raicu, G. Mihaela van Santvoort, Hjalmar C. van Velthuysen, Marie-Louise Verheij, Joanne Besselink, Marc G. Farina Sarasqueta, Arantza |
author_facet | Augustinus, Simone Schafrat, Pascale J. M. Janssen, Boris V. Bonsing, Bert A. Brosens, Lodewijk A. A. Busch, Olivier R. Crobach, Stijn Doukas, Michail van Eijck, Casper H. van der Geest, Lydia G. M. Groot Koerkamp, Bas de Hingh, Ignace H. J. T. Raicu, G. Mihaela van Santvoort, Hjalmar C. van Velthuysen, Marie-Louise Verheij, Joanne Besselink, Marc G. Farina Sarasqueta, Arantza |
author_sort | Augustinus, Simone |
collection | PubMed |
description | BACKGROUND: Surgeons aim for R0 resection in patients with pancreatic cancer to improve overall survival. However, it is unclear whether recent changes in pancreatic cancer care such as centralization, increased use of neoadjuvant therapy, minimally invasive surgery, and standardized pathology reporting have influenced R0 resections and whether R0 resection remains associated with overall survival. METHODS: This nationwide retrospective cohort study included consecutive patients after pancreatoduodenectomy (PD) for pancreatic cancer from the Netherlands Cancer Registry and the Dutch Nationwide Pathology Database (2009–2019). R0 resection was defined as > 1 mm tumor clearance at the pancreatic, posterior, and vascular resection margins. Completeness of pathology reporting was scored on the basis of six elements: histological diagnosis, tumor origin, radicality, tumor size, extent of invasion, and lymph node examination. RESULTS: Among 2955 patients after PD for pancreatic cancer, the R0 resection rate was 49%. The R0 resection rate decreased from 68 to 43% (2009–2019, P < 0.001). The extent of resections in high-volume hospitals, minimally invasive surgery, neoadjuvant therapy, and complete pathology reports all significantly increased over time. Only complete pathology reporting was independently associated with lower R0 rates (OR 0.76, 95% CI 0.69–0.83, P < 0.001). Higher hospital volume, neoadjuvant therapy, and minimally invasive surgery were not associated with R0. R0 resection remained independently associated with improved overall survival (HR 0.72, 95% CI 0.66–0.79, P < 0.001), as well as in the 214 patients after neoadjuvant treatment (HR 0.61, 95% CI 0.42–0.87, P = 0.007). CONCLUSIONS: The nationwide rate of R0 resections after PD for pancreatic cancer decreased over time, mostly related to more complete pathology reporting. R0 resection remained associated with overall survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-023-13465-9. |
format | Online Article Text |
id | pubmed-10319672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-103196722023-07-06 Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer Augustinus, Simone Schafrat, Pascale J. M. Janssen, Boris V. Bonsing, Bert A. Brosens, Lodewijk A. A. Busch, Olivier R. Crobach, Stijn Doukas, Michail van Eijck, Casper H. van der Geest, Lydia G. M. Groot Koerkamp, Bas de Hingh, Ignace H. J. T. Raicu, G. Mihaela van Santvoort, Hjalmar C. van Velthuysen, Marie-Louise Verheij, Joanne Besselink, Marc G. Farina Sarasqueta, Arantza Ann Surg Oncol Pancreatic Tumors BACKGROUND: Surgeons aim for R0 resection in patients with pancreatic cancer to improve overall survival. However, it is unclear whether recent changes in pancreatic cancer care such as centralization, increased use of neoadjuvant therapy, minimally invasive surgery, and standardized pathology reporting have influenced R0 resections and whether R0 resection remains associated with overall survival. METHODS: This nationwide retrospective cohort study included consecutive patients after pancreatoduodenectomy (PD) for pancreatic cancer from the Netherlands Cancer Registry and the Dutch Nationwide Pathology Database (2009–2019). R0 resection was defined as > 1 mm tumor clearance at the pancreatic, posterior, and vascular resection margins. Completeness of pathology reporting was scored on the basis of six elements: histological diagnosis, tumor origin, radicality, tumor size, extent of invasion, and lymph node examination. RESULTS: Among 2955 patients after PD for pancreatic cancer, the R0 resection rate was 49%. The R0 resection rate decreased from 68 to 43% (2009–2019, P < 0.001). The extent of resections in high-volume hospitals, minimally invasive surgery, neoadjuvant therapy, and complete pathology reports all significantly increased over time. Only complete pathology reporting was independently associated with lower R0 rates (OR 0.76, 95% CI 0.69–0.83, P < 0.001). Higher hospital volume, neoadjuvant therapy, and minimally invasive surgery were not associated with R0. R0 resection remained independently associated with improved overall survival (HR 0.72, 95% CI 0.66–0.79, P < 0.001), as well as in the 214 patients after neoadjuvant treatment (HR 0.61, 95% CI 0.42–0.87, P = 0.007). CONCLUSIONS: The nationwide rate of R0 resections after PD for pancreatic cancer decreased over time, mostly related to more complete pathology reporting. R0 resection remained associated with overall survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-023-13465-9. Springer International Publishing 2023-05-20 2023 /pmc/articles/PMC10319672/ /pubmed/37210448 http://dx.doi.org/10.1245/s10434-023-13465-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Pancreatic Tumors Augustinus, Simone Schafrat, Pascale J. M. Janssen, Boris V. Bonsing, Bert A. Brosens, Lodewijk A. A. Busch, Olivier R. Crobach, Stijn Doukas, Michail van Eijck, Casper H. van der Geest, Lydia G. M. Groot Koerkamp, Bas de Hingh, Ignace H. J. T. Raicu, G. Mihaela van Santvoort, Hjalmar C. van Velthuysen, Marie-Louise Verheij, Joanne Besselink, Marc G. Farina Sarasqueta, Arantza Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer |
title | Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer |
title_full | Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer |
title_fullStr | Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer |
title_full_unstemmed | Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer |
title_short | Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer |
title_sort | nationwide impact of centralization, neoadjuvant therapy, minimally invasive surgery, and standardized pathology reporting on r0 resection and overall survival in pancreatoduodenectomy for pancreatic cancer |
topic | Pancreatic Tumors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319672/ https://www.ncbi.nlm.nih.gov/pubmed/37210448 http://dx.doi.org/10.1245/s10434-023-13465-9 |
work_keys_str_mv | AT augustinussimone nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT schafratpascalejm nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT janssenborisv nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT bonsingberta nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT brosenslodewijkaa nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT buscholivierr nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT crobachstijn nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT doukasmichail nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT vaneijckcasperh nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT vandergeestlydiagm nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT grootkoerkampbas nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT dehinghignacehjt nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT raicugmihaela nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT vansantvoorthjalmarc nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT vanvelthuysenmarielouise nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT verheijjoanne nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT besselinkmarcg nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT farinasarasquetaarantza nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer AT nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer |